Before market open on Wednesday, Biogen (NASDAQ: BIIB) unveiled its first earnings report of 2024. Happily, the company was far more profitable than many expected it to be, and investors rewarded this performance by trading the stock up by almost 5%. That compared quite favorably to the essentially flat ...
motleyfoolusx:biib
Image source: The Motley Fool. Biogen (NASDAQ: BIIB) Q1 2024 Earnings Call Apr 24, 2024, 8:30 a.m. ET Operator Continue reading
motleyfoolusx:biib
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Wednesday reported an increase in adjusted profit for the first quarter of 2024, despite a decline in revenues. Total revenue declined 7% year-over-year to $2.30 billion in the March quarter. For the full year of 2024, the company expects revenues to decline ...
alphastreetusx:biib
